Note: Ingredients listed on restricted chemical lists
EC/CAS
108-95-2
Name of the chemical
Phenol
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
7727-37-9
Name of the chemical
Nitrogen N2
Concentration
N/A
General Information
Version
6.0
Revision date
2025-07-26
Product name
Sandostatin
Chemical name
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl- D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1- (hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; [R-(R*, R*)] acetate salt
1.2.1 Relevant identified uses
Octreotide Acetate Injection is indicated to reduce blood levels
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals
GHS Information
Signal word
Not available; minimal adverse effect should occur from
Section 2
SECTION 2: Hazards identification
NFPA Rating Classification NFPA Rating
Health hazards
1 Fire Hazard 0 Reactivity Hazard 0
Signal word
Not available; minimal adverse effect should occur from Hazard statement(s), routine handling of this product. Symbol(s), and/or
Precautionary statements
(c) Description of Hazards Not available; minimal adverse effect should occur from routine handling of this product. (d) Unknown Acute Toxicity N/A
2.1 Classification of the substance or mixture
NFPA Rating Health Hazard 1 Fire Hazard 0 Reactivity Hazard 0 (b) Signal Word, Not available; minimal adverse effect should occur from Hazard statement(s), routine handling of this product.
